Bom HC: LARR Authority Can Examine Limitation Issues in Land Acquisition References under 2013 Act  ||  MP HC: Long-Serving Employees Cannot Be Denied Regularisation by Retrospective Statutory Amendments  ||  J&K&L HC: Routine Challenges to Lok Adalat Awards Defeat Their Purpose of Quick Dispute Resolution  ||  Bombay HC: Restricting Compensation For Wild Animal Damage to Select Species Violates Article 14  ||  Supreme Court: Corporate Guarantee Constitutes as Financial Debt under the IBC  ||  Supreme Court: No Right to Full Tenure Exists When Appointment is Made ‘Until Further Orders’  ||  SC Mandates Trial Courts Seek Reports on Mitigating and Aggravating Factors Before Death Sentencing  ||  Supreme Court: Schools Cannot Delay Admission of State-Allotted Student over an Eligibility Dispute  ||  J&K&L HC: Delay in Executing Preventive Detention on Unsubstantiated Medical Ground Makes it Invalid  ||  Delhi HC Allows AITA Results For Interim Management and Directs Fresh Elections Under New Sports Law    

NCLAT Sets Aside NCLT Order Approving Dhanuka's Bid for Orchid Pharma - (19 Nov 2019)

INSOLVENCY

National Company Law Appellate Tribunal has rejected the bid of Dhanuka Laboratories for the debt ridden Orchid Pharma, and vacated the order passed by the National Company Law Tribunal, Chennai which had earlier approved its resolution plan. The Appellate Tribunal observed that the approved resolution value, which stood at Rs 1,146.04 crore, proposed by Dhanuka Laboratories was lower than the liquidation value of Rs 1,309 crore of the company.

Tags : NCLAT   ORCHID PHARMA  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved